Characterization and modification of the carboxy-terminal sequences of bluetongue virus type 10 NS1 protein in relation to tubule formation and location of an antigenic epitope in the vicinity of the carboxy terminus of the protein

Bluetongue virus produces large numbers of tubules during infection. The tubules are formed from a 552-amino-acid, 64-kDa NS1 protein encoded by the viral double-stranded RNA segment M6. A series of deletion and extension mutants of bluetongue virus serotype 10 NS1 has been generated and expressed in insect cells in order to identify the carboxy-terminal components of the protein which are important for tubule formation. The mutants AcCT5 and AcCT10, lacking 5 and 10 of the carboxy-terminal residues, respectively, were prepared. By analyzing their abilities to form tubules, it was shown that AcCT5 was capable of this function whereas AcCT10 was not, indicating that the last five amino acids are not strongly involved in NS1 tubule formation. Extension mutants including foreign antigenic sequences involving up to 16 amino acids added to the C terminus of NS1 were shown to form tubules, although an extension of 19 amino acids inhibited tubule formation. Analysis of a panel of monoclonal antibodies has established that an NS1 antigenic site is located near the carboxy terminus of the protein. It appears to be exposed on the surface of tubules. The opportunities to develop new vaccines using recombinant NS1 to deliver foreign epitopes are discussed.

[1]  P. Roy,et al.  Mutation of either of two cysteine residues or deletion of the amino or carboxy terminus of nonstructural protein NS1 of bluetongue virus abrogates virus-specified tubule formation in insect cells , 1994, Journal of virology.

[2]  A. Gould,et al.  Expression of the non-structural protein NS1 of bluetongue virus in bacteria and yeast: identification of two antigenic sites at the amino terminus. , 1994, Virus research.

[3]  A. Burny,et al.  Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51 , 1993, Journal of virology.

[4]  I. Jones,et al.  Recombinant Baculovirus Vectors Expressing Glutathione–S–Transferase Fusion Proteins , 1993, Bio/Technology.

[5]  Kitts Pa,et al.  A method for producing recombinant baculovirus expression vectors at high frequency. , 1993 .

[6]  A. Hyatt,et al.  Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. , 1993, Virology.

[7]  S. Ueda,et al.  The complete sequence of African horsesickness virus serotype 4 (vaccine strain) RNA segment 5 and its predicted polypeptide compared with NS1 of bluetongue virus. , 1992, The Journal of general virology.

[8]  D. Dunigan,et al.  The Baculovirus Expression System: A Laboratory Guide , 1992 .

[9]  L. Nel,et al.  A characterization of the nonstructural protein from which the virus-specified tubules in epizootic haemorrhagic disease virus-infected cells are composed. , 1991, Virus research.

[10]  P. Roy,et al.  Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV , 1990, Journal of virology.

[11]  P. Roy,et al.  Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10 , 1988, Journal of virology.

[12]  A. Gould,et al.  Nucleotide and deduced amino acid sequences of the non-structural protein, NS1, of Australian and South African bluetongue virus serotype 1. , 1988, Virus research.

[13]  J. White,et al.  Localization of the nonstructural protein NS1 in bluetongue virus-infected cells and its presence in virus particles. , 1988, Virology.

[14]  B. Eaton,et al.  Ultrastructural distribution of the major capsid proteins within bluetongue virus and infected cells. , 1988, The Journal of general virology.

[15]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Roy,et al.  Complete sequence of the NS1 gene (S6 RNA) of US bluetongue virus serotype 17. , 1987 .

[17]  M. Cloete,et al.  A comparison of different cloned bluetongue virus genome segments as probes for the detection of virus-specified RNA. , 1987, Virology.

[18]  E. Gould,et al.  Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus. , 1986, Virology.

[19]  E. Gould,et al.  Use of the biotin-streptavidin interaction to improve flavivirus detection by immunofluorescence and ELISA tests. , 1985, Journal of virological methods.

[20]  K. Yasui,et al.  Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies , 1983, Journal of virology.

[21]  H. Huismans Protein synthesis in bluetongue virus-infected cells. , 1979, Virology.

[22]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Martha J. Brown,et al.  A Plaque Assay for Nuclear Polyhedrosis Viruses using a Solid Overlay , 1977 .

[24]  E. Borden,et al.  Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies. , 1971, The Journal of general virology.

[25]  Y. Yang,et al.  High-sequence conservation among the United States bluetongue viruses cognate M2 genes which encode the nonstructural NS1 tubule protein. , 1993, Virology.

[26]  P. Roy,et al.  3-D reconstruction of bluetongue virus tubules using cryoelectron microscopy. , 1992, Journal of structural biology.

[27]  P. Roy,et al.  Structure of the bluetongue virus genome and its encoded proteins. , 1990, Current topics in microbiology and immunology.